Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Progesterone and bone: actions promoting bone health in women.

Journal of osteoporosis

Seifert-Klauss V, Prior JC.
PMID: 21052538
J Osteoporos. 2010 Oct 31;2010:845180. doi: 10.4061/2010/845180.

Estradiol (E(2)) and progesterone (P(4)) collaborate within bone remodelling on resorption (E(2)) and formation (P(4)). We integrate evidence that P(4) may prevent and, with antiresorptives, treat women's osteoporosis. P(4) stimulates osteoblast differentiation in vitro. Menarche (E(2)) and onset of...

Cite
Seifert-Klauss V, Prior JC. Progesterone and bone: actions promoting bone health in women. J Osteoporos. 2010;2010:845180doi: 10.4061/2010/845180.
Seifert-Klauss, V., & Prior, J. C. (2010). Progesterone and bone: actions promoting bone health in women. Journal of osteoporosis, 2010845180. https://doi.org/10.4061/2010/845180
Seifert-Klauss, Vanadin, and Prior, Jerilynn C. "Progesterone and bone: actions promoting bone health in women." Journal of osteoporosis vol. 2010 (2010): 845180. doi: https://doi.org/10.4061/2010/845180
Seifert-Klauss V, Prior JC. Progesterone and bone: actions promoting bone health in women. J Osteoporos. 2010 Oct 31;2010:845180. doi: 10.4061/2010/845180. PMID: 21052538; PMCID: PMC2968416.
Copy Download .nbib Format: NLM
C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?.

Geburtshilfe und Frauenheilkunde

Stassek J, Erdmann J, Ohnolz F, Berg FD, Kiechle M, Seifert-Klauss V.
PMID: 28190890
Geburtshilfe Frauenheilkd. 2017 Jan;77(1):59-65. doi: 10.1055/s-0042-119199.

No abstract available.

Cite
Stassek J, Erdmann J, Ohnolz F, et al. C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?. Geburtshilfe Frauenheilkd. 2017;77(1):59-65doi: 10.1055/s-0042-119199.
Stassek, J., Erdmann, J., Ohnolz, F., Berg, F. D., Kiechle, M., & Seifert-Klauss, V. (2017). C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?. Geburtshilfe und Frauenheilkunde, 77(1), 59-65. https://doi.org/10.1055/s-0042-119199
Stassek, J, et al. "C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?." Geburtshilfe und Frauenheilkunde vol. 77,1 (2017): 59-65. doi: https://doi.org/10.1055/s-0042-119199
Stassek J, Erdmann J, Ohnolz F, Berg FD, Kiechle M, Seifert-Klauss V. C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal - Evidence for an Increased Insulin Clearance in PCOS Patients?. Geburtshilfe Frauenheilkd. 2017 Jan;77(1):59-65. doi: 10.1055/s-0042-119199. PMID: 28190890; PMCID: PMC5292905.
Copy Download .nbib Format: NLM
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Geburtshilfe und Frauenheilkunde

Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D.
PMID: 31423017
Geburtshilfe Frauenheilkd. 2019 Aug;79(8):813-833. doi: 10.1055/a-0903-2735. Epub 2019 Aug 12.

No abstract available.

Cite
Berger R, Abele H, Bahlmann F, et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe Frauenheilkd. 2019;79(8):813-833doi: 10.1055/a-0903-2735.
Berger, R., Abele, H., Bahlmann, F., Bedei, I., Doubek, K., Felderhoff-Müser, U., Fluhr, H., Garnier, Y., Grylka-Baeschlin, S., Helmer, H., Herting, E., Hoopmann, M., Hösli, I., Hoyme, U., Jendreizeck, A., Krentel, H., Kuon, R., Lütje, W., Mader, S., Maul, H., Mendling, W., Mitschdörfer, B., Nicin, T., Nothacker, M., Olbertz, D., Rath, W., Roll, C., Schlembach, D., Schleußner, E., Schütz, F., Seifert-Klauss, V., Steppat, S., & Surbek, D. (2019). Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe und Frauenheilkunde, 79(8), 813-833. https://doi.org/10.1055/a-0903-2735
Berger, Richard, et al. "Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes." Geburtshilfe und Frauenheilkunde vol. 79,8 (2019): 813-833. doi: https://doi.org/10.1055/a-0903-2735
Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe Frauenheilkd. 2019 Aug;79(8):813-833. doi: 10.1055/a-0903-2735. Epub 2019 Aug 12. PMID: 31423017; PMCID: PMC6690742.
Copy Download .nbib Format: NLM
Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman.

Geburtshilfe und Frauenheilkunde

Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J.
PMID: 31875858
Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1278-1292. doi: 10.1055/a-1017-3389. Epub 2019 Dec 11.

No abstract available.

Cite
Toth B, Baston-Büst DM, Behre HM, et al. Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman. Geburtshilfe Frauenheilkd. 2019;79(12):1278-1292doi: 10.1055/a-1017-3389.
Toth, B., Baston-Büst, D. M., Behre, H. M., Bielfeld, A., Bohlmann, M., Bühling, K., Dittrich, R., Goeckenjan, M., Hancke, K., Kliesch, S., Köhn, F. M., Krüssel, J., Kuon, R., Liebenthron, J., Nawroth, F., Nordhoff, V., Pinggera, G. M., Rogenhofer, N., Rudnik-Schöneborn, S., Schuppe, H. C., Schüring, A., Seifert-Klauss, V., Strowitzki, T., Tüttelmann, F., Vomstein, K., Wildt, L., Wischmann, T., Wunder, D., & Zschocke, J. (2019). Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman. Geburtshilfe und Frauenheilkunde, 79(12), 1278-1292. https://doi.org/10.1055/a-1017-3389
Toth, Bettina, et al. "Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman." Geburtshilfe und Frauenheilkunde vol. 79,12 (2019): 1278-1292. doi: https://doi.org/10.1055/a-1017-3389
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J. Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman. Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1278-1292. doi: 10.1055/a-1017-3389. Epub 2019 Dec 11. PMID: 31875858; PMCID: PMC6924329.
Copy Download .nbib Format: NLM
Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture.

Geburtshilfe und Frauenheilkunde

Prior JC, Hitchcock CL, Vigna YM, Seifert-Klauss V.
PMID: 27582584
Geburtshilfe Frauenheilkd. 2016 Aug;76(8):895-901. doi: 10.1055/s-0042-103751.

INTRODUCTION: Although a fragility fracture family history (FFFH+) has repeatedly been shown to be associated with lower bone mineral density (BMD), its relationship to human BMD PARTICIPANTS AND METHODS: Healthy premenopausal community women participated in prospective observational studies at...

Cite
Prior JC, Hitchcock CL, Vigna YM, et al. Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture. Geburtshilfe Frauenheilkd. 2016;76(8):895-901doi: 10.1055/s-0042-103751.
Prior, J. C., Hitchcock, C. L., Vigna, Y. M., & Seifert-Klauss, V. (2016). Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture. Geburtshilfe und Frauenheilkunde, 76(8), 895-901. https://doi.org/10.1055/s-0042-103751
Prior, J C, et al. "Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture." Geburtshilfe und Frauenheilkunde vol. 76,8 (2016): 895-901. doi: https://doi.org/10.1055/s-0042-103751
Prior JC, Hitchcock CL, Vigna YM, Seifert-Klauss V. Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture. Geburtshilfe Frauenheilkd. 2016 Aug;76(8):895-901. doi: 10.1055/s-0042-103751. PMID: 27582584; PMCID: PMC5000784.
Copy Download .nbib Format: NLM
Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]).

Geburtshilfe und Frauenheilkunde

Stassek J, Ohnolz F, Hanusch Y, Schmidmayr M, Berg D, Kiechle M, Seifert-Klauss VR.
PMID: 26719599
Geburtshilfe Frauenheilkd. 2015 Nov;75(11):1153-1160. doi: 10.1055/s-0035-1558186.

No abstract available.

Cite
Stassek J, Ohnolz F, Hanusch Y, et al. Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]). Geburtshilfe Frauenheilkd. 2015;75(11):1153-1160doi: 10.1055/s-0035-1558186.
Stassek, J., Ohnolz, F., Hanusch, Y., Schmidmayr, M., Berg, D., Kiechle, M., & Seifert-Klauss, V. R. (2015). Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]). Geburtshilfe und Frauenheilkunde, 75(11), 1153-1160. https://doi.org/10.1055/s-0035-1558186
Stassek, J, et al. "Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS])." Geburtshilfe und Frauenheilkunde vol. 75,11 (2015): 1153-1160. doi: https://doi.org/10.1055/s-0035-1558186
Stassek J, Ohnolz F, Hanusch Y, Schmidmayr M, Berg D, Kiechle M, Seifert-Klauss VR. Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS]). Geburtshilfe Frauenheilkd. 2015 Nov;75(11):1153-1160. doi: 10.1055/s-0035-1558186. PMID: 26719599; PMCID: PMC4678050.
Copy Download .nbib Format: NLM
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth.

Geburtshilfe und Frauenheilkunde

Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D.
PMID: 31423016
Geburtshilfe Frauenheilkd. 2019 Aug;79(8):800-812. doi: 10.1055/a-0903-2671. Epub 2019 Aug 12.

No abstract available.

Cite
Berger R, Abele H, Bahlmann F, et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth. Geburtshilfe Frauenheilkd. 2019;79(8):800-812doi: 10.1055/a-0903-2671.
Berger, R., Abele, H., Bahlmann, F., Bedei, I., Doubek, K., Felderhoff-Müser, U., Fluhr, H., Garnier, Y., Grylka-Baeschlin, S., Helmer, H., Herting, E., Hoopmann, M., Hösli, I., Hoyme, U., Jendreizeck, A., Krentel, H., Kuon, R., Lütje, W., Mader, S., Maul, H., Mendling, W., Mitschdörfer, B., Nicin, T., Nothacker, M., Olbertz, D., Rath, W., Roll, C., Schlembach, D., Schleußner, E., Schütz, F., Seifert-Klauss, V., Steppat, S., & Surbek, D. (2019). Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth. Geburtshilfe und Frauenheilkunde, 79(8), 800-812. https://doi.org/10.1055/a-0903-2671
Berger, Richard, et al. "Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth." Geburtshilfe und Frauenheilkunde vol. 79,8 (2019): 800-812. doi: https://doi.org/10.1055/a-0903-2671
Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth. Geburtshilfe Frauenheilkd. 2019 Aug;79(8):800-812. doi: 10.1055/a-0903-2671. Epub 2019 Aug 12. PMID: 31423016; PMCID: PMC6690739.
Copy Download .nbib Format: NLM
Mammographic Density and Vitamin D Levels - A Cross-sectional Study.

Geburtshilfe und Frauenheilkunde

Straub L, Riedel J, Luppa PB, Wissing J, Artmann A, Kiechle M, Seifert-Klauss VR.
PMID: 28392579
Geburtshilfe Frauenheilkd. 2017 Mar;77(3):257-267. doi: 10.1055/s-0043-102694.

No abstract available.

Cite
Straub L, Riedel J, Luppa PB, et al. Mammographic Density and Vitamin D Levels - A Cross-sectional Study. Geburtshilfe Frauenheilkd. 2017;77(3):257-267doi: 10.1055/s-0043-102694.
Straub, L., Riedel, J., Luppa, P. B., Wissing, J., Artmann, A., Kiechle, M., & Seifert-Klauss, V. R. (2017). Mammographic Density and Vitamin D Levels - A Cross-sectional Study. Geburtshilfe und Frauenheilkunde, 77(3), 257-267. https://doi.org/10.1055/s-0043-102694
Straub, Loreen, et al. "Mammographic Density and Vitamin D Levels - A Cross-sectional Study." Geburtshilfe und Frauenheilkunde vol. 77,3 (2017): 257-267. doi: https://doi.org/10.1055/s-0043-102694
Straub L, Riedel J, Luppa PB, Wissing J, Artmann A, Kiechle M, Seifert-Klauss VR. Mammographic Density and Vitamin D Levels - A Cross-sectional Study. Geburtshilfe Frauenheilkd. 2017 Mar;77(3):257-267. doi: 10.1055/s-0043-102694. PMID: 28392579; PMCID: PMC5383429.
Copy Download .nbib Format: NLM
Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles.

Geburtshilfe und Frauenheilkunde

Niethammer B, Körner C, Schmidmayr M, Luppa PB, Seifert-Klauss VR.
PMID: 26726266
Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1250-1257. doi: 10.1055/s-0035-1558298.

No abstract available.

Cite
Niethammer B, Körner C, Schmidmayr M, et al. Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles. Geburtshilfe Frauenheilkd. 2015;75(12):1250-1257doi: 10.1055/s-0035-1558298.
Niethammer, B., Körner, C., Schmidmayr, M., Luppa, P. B., & Seifert-Klauss, V. R. (2015). Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles. Geburtshilfe und Frauenheilkunde, 75(12), 1250-1257. https://doi.org/10.1055/s-0035-1558298
Niethammer, B, et al. "Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles." Geburtshilfe und Frauenheilkunde vol. 75,12 (2015): 1250-1257. doi: https://doi.org/10.1055/s-0035-1558298
Niethammer B, Körner C, Schmidmayr M, Luppa PB, Seifert-Klauss VR. Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles. Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1250-1257. doi: 10.1055/s-0035-1558298. PMID: 26726266; PMCID: PMC4686368.
Copy Download .nbib Format: NLM
Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.

Geburtshilfe und Frauenheilkunde

Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J.
PMID: 31875859
Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1293-1308. doi: 10.1055/a-1017-3478. Epub 2019 Dec 11.

No abstract available.

Cite
Toth B, Baston-Büst DM, Behre HM, et al. Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. Geburtshilfe Frauenheilkd. 2019;79(12):1293-1308doi: 10.1055/a-1017-3478.
Toth, B., Baston-Büst, D. M., Behre, H. M., Bielfeld, A., Bohlmann, M., Bühling, K., Dittrich, R., Goeckenjan, M., Hancke, K., Kliesch, S., Köhn, F. M., Krüssel, J., Kuon, R., Liebenthron, J., Nawroth, F., Nordhoff, V., Pinggera, G. M., Rogenhofer, N., Rudnik-Schöneborn, S., Schuppe, H. C., Schüring, A., Seifert-Klauss, V., Strowitzki, T., Tüttelmann, F., Vomstein, K., Wildt, L., Wischmann, T., Wunder, D., & Zschocke, J. (2019). Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. Geburtshilfe und Frauenheilkunde, 79(12), 1293-1308. https://doi.org/10.1055/a-1017-3478
Toth, Bettina, et al. "Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease." Geburtshilfe und Frauenheilkunde vol. 79,12 (2019): 1293-1308. doi: https://doi.org/10.1055/a-1017-3478
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J. Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1293-1308. doi: 10.1055/a-1017-3478. Epub 2019 Dec 11. PMID: 31875859; PMCID: PMC6924330.
Copy Download .nbib Format: NLM
Vitamin D and Mammographic Findings.

Geburtshilfe und Frauenheilkunde

Riedel J, Straub L, Wissing J, Artmann A, Schmidmayr M, Kiechle M, Seifert-Klauss VR.
PMID: 27239067
Geburtshilfe Frauenheilkd. 2016 May;76(5):570-578. doi: 10.1055/s-0042-106208.

No abstract available.

Cite
Riedel J, Straub L, Wissing J, et al. Vitamin D and Mammographic Findings. Geburtshilfe Frauenheilkd. 2016;76(5):570-578doi: 10.1055/s-0042-106208.
Riedel, J., Straub, L., Wissing, J., Artmann, A., Schmidmayr, M., Kiechle, M., & Seifert-Klauss, V. R. (2016). Vitamin D and Mammographic Findings. Geburtshilfe und Frauenheilkunde, 76(5), 570-578. https://doi.org/10.1055/s-0042-106208
Riedel, J, et al. "Vitamin D and Mammographic Findings." Geburtshilfe und Frauenheilkunde vol. 76,5 (2016): 570-578. doi: https://doi.org/10.1055/s-0042-106208
Riedel J, Straub L, Wissing J, Artmann A, Schmidmayr M, Kiechle M, Seifert-Klauss VR. Vitamin D and Mammographic Findings. Geburtshilfe Frauenheilkd. 2016 May;76(5):570-578. doi: 10.1055/s-0042-106208. PMID: 27239067; PMCID: PMC4873293.
Copy Download .nbib Format: NLM
Use of MR-based trabecular bone microstructure analysis at the distal radius for osteoporosis diagnostics: a study in post-menopausal women with breast cancer and treated with aromatase inhibitor.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Baum T, Karampinos DC, Seifert-Klauss V, Pencheva TD, Jungmann PM, Rummeny EJ, Müller D, Bauer JS.
PMID: 27252740
Clin Cases Miner Bone Metab. 2016 Jan-Apr;13(1):29-32. doi: 10.11138/ccmbm/2016.13.1.029. Epub 2016 May 11.

PURPOSE: Treatment with aromatase inhibitor (AI) is recommended for post-menopausal women with hormone-receptor positive breast cancer. However, AI therapy is known to induce bone loss leading to osteoporosis with an increased risk for fragility fractures. The purpose of this...

Cite
Baum T, Karampinos DC, Seifert-Klauss V, et al. Use of MR-based trabecular bone microstructure analysis at the distal radius for osteoporosis diagnostics: a study in post-menopausal women with breast cancer and treated with aromatase inhibitor. Clin Cases Miner Bone Metab. 2016;13(1):29-32doi: 10.11138/ccmbm/2016.13.1.029.
Baum, T., Karampinos, D. C., Seifert-Klauss, V., Pencheva, T. D., Jungmann, P. M., Rummeny, E. J., Müller, D., & Bauer, J. S. (2016). Use of MR-based trabecular bone microstructure analysis at the distal radius for osteoporosis diagnostics: a study in post-menopausal women with breast cancer and treated with aromatase inhibitor. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 13(1), 29-32. https://doi.org/10.11138/ccmbm/2016.13.1.029
Baum, Thomas, et al. "Use of MR-based trabecular bone microstructure analysis at the distal radius for osteoporosis diagnostics: a study in post-menopausal women with breast cancer and treated with aromatase inhibitor." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 13,1 (2016): 29-32. doi: https://doi.org/10.11138/ccmbm/2016.13.1.029
Baum T, Karampinos DC, Seifert-Klauss V, Pencheva TD, Jungmann PM, Rummeny EJ, Müller D, Bauer JS. Use of MR-based trabecular bone microstructure analysis at the distal radius for osteoporosis diagnostics: a study in post-menopausal women with breast cancer and treated with aromatase inhibitor. Clin Cases Miner Bone Metab. 2016 Jan-Apr;13(1):29-32. doi: 10.11138/ccmbm/2016.13.1.029. Epub 2016 May 11. PMID: 27252740; PMCID: PMC4869949.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries